Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online June 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2005-0554v1
24/9/2034    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazda, H. T.
Right arrow Articles by Beggs, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazda, H. T.
Right arrow Articles by Beggs, A. H.
Submitted on November 9, 2005
Accepted on May 23, 2006

Stem Cell Genetics and Genomics

Defective Ribosomal Protein Gene Expression Alters Transcription, Translation, Apoptosis And Oncogenic Pathways In Diamond-Blackfan Anemia

Hanna T. Gazda 1*, Alvin T. Kho 2, Despina Sanoudou 3, Jan M. Zaucha 4, Isaac S. Kohane 5, Colin A. Sieff 6, Alan H. Beggs 7

1 Dana Farber Cancer Institute, Department of Pediatric Oncology, Boston, Massachusetts; Children's Hospital Boston, Genomics Program and Division of Genetics, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts
2 Dana Farber Cancer Institute, Department of Pediatric Oncology, Boston, Massachusetts; Children's Hospital Boston, Children's Hospital Informatics Program, Boston, Massachusetts; Harvard University-Massachusetts Institute of Technology, Division of Health Sciences and Technology, Boston, Massachusetts
3 Children's Hospital Boston, Genomics Program and Division of Genetics, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Academy of Athens, Foundation for Biomedical Research, Athens, Greece
4 University Medical School of Gdansk, Department of Hematology/Oncology, Gdansk, Poland
5 Harvard Medical School, Boston, Massachusetts; Children's Hospital Boston, Children's Hospital Informatics Program, Boston, Massachusetts; Harvard University-Massachusetts Institute of Technology, Division of Health Sciences and Technology, Boston, Massachusetts
6 Dana Farber Cancer Institute, Department of Pediatric Oncology, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Children's Hospital Boston, Department of Hematology, Boston, Massachusetts
7 Children's Hospital Boston, Genomics Program and Division of Genetics, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

* To whom correspondence should be addressed. E-mail: hanna-gazda{at}dfci.harvard.edu.


   Abstract

Diamond-Blackfan anemia (DBA) is a broad developmental disease characterized by anemia, bone marrow (BM) erythroblastopenia, and an increased incidence of malignancy. Mutations in a ribosomal protein gene S19 (RPS19) are found in ~25% of DBA patients; however, the role of RPS19 in the pathogenesis of DBA remains unknown. Using global gene expression analysis we compared highly purified multipotential, erythroid and myeloid BM progenitors from RPS19 mutated and control individuals. We found several ribosomal protein genes down-regulated in all DBA progenitors. Apoptosis genes like TNFRSF10B and FAS, transcriptional control genes including the erythropoietic transcription factor MYB (encoding c-myb), and translational genes were greatly dysregulated mostly in diseased erythroid cells. Cancer-related genes, including RAB family oncogenes and tumor suppressor genes, were significantly dysregulated in all diseased progenitors. In addition, our results provide evidence that RPS19 mutations lead to co-downregulation of multiple ribosomal protein genes as well as down-regulation of genes involved in translation in DBA cells. In conclusion, the altered expression of cancer-related genes suggests a molecular basis for malignancy in DBA. Down-regulation of c-myb expression, which causes complete failure of fetal liver erythropoiesis in knockout mice, suggests a link between RPS19 mutations and reduced erythropoiesis in DBA.

Key Words. Diamond-Blackfan anemia, bone marrow failure, global gene expression, ribosomal protein genes, apoptosis, cancer




This article has been cited by other articles:


Home page
Stem CellsHome page
K. Miyake, T. Utsugisawa, J. Flygare, T. Kiefer, I. Hamaguchi, J. Richter, and S. Karlsson
Ribosomal Protein S19 Deficiency Leads to Reduced Proliferation and Increased Apoptosis but Does Not Affect Terminal Erythroid Differentiation in a Cell Line Model of Diamond-Blackfan Anemia
Stem Cells, February 1, 2008; 26(2): 323 - 329.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W. Goessling, T. E. North, and L. I. Zon
New Waves of Discovery: Modeling Cancer in Zebrafish
J. Clin. Oncol., June 10, 2007; 25(17): 2473 - 2479.
[Full Text] [PDF]


Home page
BloodHome page
J. Flygare and S. Karlsson
Diamond-Blackfan anemia: erythropoiesis lost in translation
Blood, April 15, 2007; 109(8): 3152 - 3154.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Choesmel, D. Bacqueville, J. Rouquette, J. Noaillac-Depeyre, S. Fribourg, A. Cretien, T. Leblanc, G. Tchernia, L. Da Costa, and P.-E. Gleizes
Impaired ribosome biogenesis in Diamond-Blackfan anemia
Blood, February 1, 2007; 109(3): 1275 - 1283.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2006 by AlphaMed Press.